These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 33525396)

  • 21. Biophysical characterization of the structure of a SARS-CoV-2 self-amplifying RNA (saRNA) vaccine.
    Myatt DP; Wharram L; Graham C; Liddell J; Branton H; Pizzey C; Cowieson N; Rambo R; Shattock RJ
    Biol Methods Protoc; 2023; 8(1):bpad001. PubMed ID: 36915370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advancing mRNA technologies for therapies and vaccines: An African context.
    Kairuz D; Samudh N; Ely A; Arbuthnot P; Bloom K
    Front Immunol; 2022; 13():1018961. PubMed ID: 36353641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Innate Inhibiting Proteins Enhance Expression and Immunogenicity of Self-Amplifying RNA.
    Blakney AK; McKay PF; Bouton CR; Hu K; Samnuan K; Shattock RJ
    Mol Ther; 2021 Mar; 29(3):1174-1185. PubMed ID: 33352107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonviral delivery of self-amplifying RNA vaccines.
    Geall AJ; Verma A; Otten GR; Shaw CA; Hekele A; Banerjee K; Cu Y; Beard CW; Brito LA; Krucker T; O'Hagan DT; Singh M; Mason PW; Valiante NM; Dormitzer PR; Barnett SW; Rappuoli R; Ulmer JB; Mandl CW
    Proc Natl Acad Sci U S A; 2012 Sep; 109(36):14604-9. PubMed ID: 22908294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell-mediated immunity.
    McCafferty S; Haque AKMA; Vandierendonck A; Weidensee B; Plovyt M; Stuchlíková M; François N; Valembois S; Heyndrickx L; Michiels J; Ariën KK; Vandekerckhove L; Abdelnabi R; Foo CS; Neyts J; Sahu I; Sanders NN
    Mol Ther; 2022 Sep; 30(9):2968-2983. PubMed ID: 35450821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Nonmonotonic Dose Dependence of Protein Expression in Cells Transfected with Self-Amplifying RNA.
    Tanimoto CR; Thurm AR; Brandt DS; Knobler CM; Gelbart WM
    J Virol; 2022 Apr; 96(7):e0185821. PubMed ID: 35293773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polyethylenimine-based polyplex delivery of self-replicating RNA vaccines.
    Démoulins T; Milona P; Englezou PC; Ebensen T; Schulze K; Suter R; Pichon C; Midoux P; Guzmán CA; Ruggli N; McCullough KC
    Nanomedicine; 2016 Apr; 12(3):711-722. PubMed ID: 26592962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity of stabilized HIV-1 Env trimers delivered by self-amplifying mRNA.
    Aldon Y; McKay PF; Moreno Herrero J; Vogel AB; Lévai R; Maisonnasse P; Dereuddre-Bosquet N; Haas H; Fábián K; Le Grand R; Sahin U; Shattock RJ
    Mol Ther Nucleic Acids; 2021 Sep; 25():483-493. PubMed ID: 34589271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement of In Vivo Expression of Genes Delivered by Self-Amplifying RNA Using Vaccinia Virus Immune Evasion Proteins.
    Beissert T; Koste L; Perkovic M; Walzer KC; Erbar S; Selmi A; Diken M; Kreiter S; Türeci Ö; Sahin U
    Hum Gene Ther; 2017 Dec; 28(12):1138-1146. PubMed ID: 28877647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Skin You Are In: Design-of-Experiments Optimization of Lipid Nanoparticle Self-Amplifying RNA Formulations in Human Skin Explants.
    Blakney AK; McKay PF; Ibarzo Yus B; Hunter JE; Dex EA; Shattock RJ
    ACS Nano; 2019 May; 13(5):5920-5930. PubMed ID: 31046232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rise of the RNA machines - self-amplification in mRNA vaccine design.
    Comes JDG; Pijlman GP; Hick TAH
    Trends Biotechnol; 2023 Nov; 41(11):1417-1429. PubMed ID: 37328401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymer formulated self-amplifying RNA vaccine is partially protective against influenza virus infection in ferrets.
    McKay PF; Zhou J; Frise R; Blakney AK; Bouton CR; Wang Z; Hu K; Samnuan K; Brown JC; Kugathasan R; Yeow J; Stevens MM; Barclay WS; Tregoning JS; Shattock RJ
    Oxf Open Immunol; 2022; 3(1):iqac004. PubMed ID: 35996628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design Strategies for and Stability of mRNA-Lipid Nanoparticle COVID-19 Vaccines.
    Liu T; Tian Y; Zheng A; Cui C
    Polymers (Basel); 2022 Oct; 14(19):. PubMed ID: 36236141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-Replicating RNA Vaccine Delivery to Dendritic Cells.
    Démoulins T; Englezou PC; Milona P; Ruggli N; Tirelli N; Pichon C; Sapet C; Ebensen T; Guzmán CA; McCullough KC
    Methods Mol Biol; 2017; 1499():37-75. PubMed ID: 27987142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intratumoral electroporation of a self-amplifying RNA expressing IL-12 induces antitumor effects in mouse models of cancer.
    Silva-Pilipich N; Lasarte-Cía A; Lozano T; Martín-Otal C; Lasarte JJ; Smerdou C
    Mol Ther Nucleic Acids; 2022 Sep; 29():387-399. PubMed ID: 36035753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Self-amplifying mRNA-Based Vaccine Technology and Its Mode of Action.
    Maruggi G; Ulmer JB; Rappuoli R; Yu D
    Curr Top Microbiol Immunol; 2022; 440():31-70. PubMed ID: 33861374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. saRNA vaccine expressing membrane-anchored RBD elicits broad and durable immunity against SARS-CoV-2 variants of concern.
    Komori M; Nogimori T; Morey AL; Sekida T; Ishimoto K; Hassett MR; Masuta Y; Ode H; Tamura T; Suzuki R; Alexander J; Kido Y; Matsuda K; Fukuhara T; Iwatani Y; Yamamoto T; Smith JF; Akahata W
    Nat Commun; 2023 May; 14(1):2810. PubMed ID: 37208330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-amplifying mRNA vaccines.
    Brito LA; Kommareddy S; Maione D; Uematsu Y; Giovani C; Berlanda Scorza F; Otten GR; Yu D; Mandl CW; Mason PW; Dormitzer PR; Ulmer JB; Geall AJ
    Adv Genet; 2015; 89():179-233. PubMed ID: 25620012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mannosylation of LNP Results in Improved Potency for Self-Amplifying RNA (SAM) Vaccines.
    Goswami R; Chatzikleanthous D; Lou G; Giusti F; Bonci A; Taccone M; Brazzoli M; Gallorini S; Ferlenghi I; Berti F; O'Hagan DT; Pergola C; Baudner BC; Adamo R
    ACS Infect Dis; 2019 Sep; 5(9):1546-1558. PubMed ID: 31290323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The evaluation of novel oral vaccines based on self-amplifying RNA lipid nanparticles (saRNA LNPs), saRNA transfected Lactobacillus plantarum LNPs, and saRNA transfected Lactobacillus plantarum to neutralize SARS-CoV-2 variants alpha and delta.
    Keikha R; Hashemi-Shahri SM; Jebali A
    Sci Rep; 2021 Oct; 11(1):21308. PubMed ID: 34716391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.